In the Journals

This feature offers timely executive summaries of the most relevant journals in rheumatology. Through peer “Perspectives,” full bibliographical information and links to the original journal abstract, In the Journals are a step wider and deeper than journal reviews health care professionals may be accustomed.

In the Journals

Patient-reported outcome measures with Skindex may yield more comprehensive data

September 19, 2019
Relying primarily on patient global assessments falls short in determining comprehensive disease severity, but by adding the Skindex instrument or…
In the Journals

Adalimumab, IBI303 biosimilar demonstrate comparable safety, efficacy in AS

September 19, 2019
IBI303, a biosimilar to adalimumab developed by Chinese biopharmaceutical company Innovent Biologics, is comparable in safety and efficacy to the…
In the Journals

Infusion reactions to rituximab more significant in SLE than other diseases

September 17, 2019
Infusion reaction rates to rituximab may be more significant among patients with systemic lupus erythematosus than other diseases, according to…
In the Journals

Newly diagnosed cases of AS at increased risk for IMIDs, lower risk for RA

September 16, 2019
Newly diagnosed patients with ankylosing spondylitis in Taiwan demonstrate increased risks for multiple immune-mediated inflammatory diseases…
In the Journals

Patients with low-disease RA on tofacitinib, methotrexate can safely withdraw methotrexate

September 12, 2019
Patients with rheumatoid arthritis who achieve low disease activity with tofacitinib plus methotrexate can safely withdraw methotrexate without fear…
In the Journals

Stress ‘primary driver’ for fatigue in patients with SLE

September 12, 2019
Although depression and stress are both predictors of fatigue among patients with systemic lupus erythematosus at 1 year, stress is the…
In the Journals

Quarter of axial SpA patients attain inactive disease after 6 months on first TNF inhibitor

September 11, 2019
Among patients with axial spondyloarthritis receiving their first TNF inhibitor, 27% achieve inactive disease, defined by the Ankylosing Spondylitis…
In the Journals

Patient-reported symptoms linked to disease activity changes in SSc

September 10, 2019
Patient-reported symptoms are associated with clinically impactful changes in systemic sclerosis disease activity, according to findings published in…
In the Journals

Number of prior DMARDs, disease duration linked to diminished drug response in RA

September 9, 2019
Longer disease duration and a greater number of previous DMARDs in a patient’s history is associated with decreased response rates to…
In the JournalsPerspective

Patients with gout have 30% higher risk for chronic kidney disease

September 9, 2019
Gout is associated with a 29% increased risk for developing advanced chronic kidney disease and a 210% increased risk for end-stage renal disease…